Heusch P, Canton M, Aker S, van de Sand A, Konietzka I, Rassaf T, Menazza S, Brodde O E, Di Lisa F, Heusch G, Schulz R
Institute of Pathophysiology, University of Essen Medical School, Essen, Germany.
Br J Pharmacol. 2010 Jul;160(6):1408-16. doi: 10.1111/j.1476-5381.2010.00793.x.
The formation of reactive oxygen species (ROS) is increased in heart failure (HF). However, the causal and mechanistic relationship of ROS formation with contractile dysfunction is not clear in detail. Therefore, ROS formation, myofibrillar protein oxidation and p38 MAP kinase activation were related to contractile function in failing rabbit hearts.
Three weeks of rapid left ventricular (LV) pacing reduced LV shortening fraction (SF, echocardiography) from 32 +/- 1% to 13 +/- 1%. ROS formation, as assessed by dihydroethidine staining, increased by 36 +/- 8% and was associated with increased tropomyosin oxidation, as reflected by dimer formation (dimer to monomer ratio increased 2.28 +/- 0.66-fold in HF vs. sham, P < 0.05). Apoptosis (TdT-mediated dUTP nick end labelling staining) increased more than 12-fold after 3 weeks of pacing when a significant increase in the phosphorylation of p38 MAP kinase and HSP27 was detected (Western blotting). Vitamins C and E abolished the increases in ROS formation and tropomyosin oxidation along with an improvement of LVSF (19 +/- 1%, P < 0.05 vs. untreated HF) and prevention of apoptosis, but without modifying p38 MAP kinase activation. Inhibition of p38 MAP kinase by SB281832 counteracted ROS formation, tropomyosin oxidation and contractile failure, without affecting apoptosis.
Thus, p38 MAP kinase activation appears to be upstream rather than downstream of ROS, which impacts on LV function through myofibrillar oxidation. p38 MAP kinase inhibition is a potential target to prevent or treat HF.
心力衰竭(HF)时活性氧(ROS)生成增加。然而,ROS生成与收缩功能障碍之间的因果及机制关系尚不清楚。因此,在衰竭兔心脏中研究了ROS生成、肌原纤维蛋白氧化和p38丝裂原活化蛋白激酶(MAP激酶)激活与收缩功能的关系。
快速左心室(LV)起搏3周使LV缩短分数(SF,超声心动图测量)从32±1%降至13±1%。通过二氢乙锭染色评估,ROS生成增加36±8%,并与原肌球蛋白氧化增加相关,表现为二聚体形成增加(HF组二聚体与单体比例比假手术组增加2.28±0.66倍,P<0.05)。起搏3周后凋亡(TdT介导的dUTP缺口末端标记染色)增加超过12倍,同时检测到p38 MAP激酶和热休克蛋白27(HSP27)磷酸化显著增加(蛋白质印迹法)。维生素C和E消除了ROS生成和原肌球蛋白氧化的增加,同时改善了LV SF(19±1%,与未治疗的HF组相比P<0.05)并预防了凋亡,但未改变p38 MAP激酶激活。SB281832抑制p38 MAP激酶可抵消ROS生成、原肌球蛋白氧化和收缩功能衰竭,但不影响凋亡。
因此,p38 MAP激酶激活似乎位于ROS的上游而非下游,ROS通过肌原纤维氧化影响LV功能。抑制p38 MAP激酶是预防或治疗HF的潜在靶点。